• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

感染问题述评:聚焦一些发病机制、临床及流行病学方面

Commentary on the Issue of Infection: Focus on Some Pathogenetic, Clinical, and Epidemiological Aspects.

作者信息

Hanau Stefania, Maritati Martina, Contini Carlo, Trentini Alessandro, Manfrinato Maria Cristina, Almugadam Shawgi Hago

机构信息

Department of Neuroscience & Rehabilitation, University of Ferrara, 44124 Ferrara, Italy.

Department of Translational Medicine and for Romagna, University of Ferrara, 44124 Ferrara, Italy.

出版信息

Vet Sci. 2025 Jun 1;12(6):536. doi: 10.3390/vetsci12060536.

DOI:10.3390/vetsci12060536
PMID:40559773
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12197631/
Abstract

Leishmaniasis are infectious diseases caused by several parasitic species of , mainly transmitted by the bite of infected phlebotomine sandflies. Humans, dogs, rodents, and other domestic and wild animals can act as reservoir hosts for the different species. It is a neglected tropical disease that is endemic in Asia, the Middle East, North and East Africa, the Mediterranean region, and South and Central America. Clinical manifestations and disease severity depend on the species of the infecting parasites and the immunity status of the host. represses the protective host immune response by manipulating the macrophage function, subverting cytokine expression to favor its survival and dissemination. A balance between pro-inflammatory and regulatory cells is necessary to bring a positive outcome. Accurate diagnosis and effective treatment represent the cornerstone in the control of this disease, although these are difficult in an environment of precariousness and poverty. Some recent studies highlighted the progressing work on diagnosis and treatments, such as the development of new benzimidazole-triazole derivatives for blocking the parasite growth, feline leishmaniasis with a comparison of immune responses in cats and dogs, and a transglutaminase that has been purified from . The results of these studies could open new avenues in combating leishmaniasis.

摘要

利什曼病是由几种利什曼原虫属寄生虫引起的传染病,主要通过受感染的白蛉叮咬传播。人类、狗、啮齿动物以及其他家养和野生动物可作为不同利什曼原虫物种的储存宿主。它是一种被忽视的热带病,在亚洲、中东、北非和东非、地中海地区以及南美洲和中美洲流行。临床表现和疾病严重程度取决于感染寄生虫的种类和宿主的免疫状态。利什曼原虫通过操纵巨噬细胞功能、颠覆细胞因子表达以利于其生存和传播,从而抑制保护性宿主免疫反应。促炎细胞和调节性细胞之间的平衡对于取得积极结果至关重要。准确诊断和有效治疗是控制该疾病的基石,尽管在不稳定和贫困的环境中做到这些很困难。最近的一些研究突出了在诊断和治疗方面取得的进展,例如开发用于阻断寄生虫生长的新型苯并咪唑 - 三唑衍生物、比较猫和狗免疫反应的猫利什曼病,以及从利什曼原虫中纯化出的一种转谷氨酰胺酶。这些研究结果可能为对抗利什曼病开辟新途径。

相似文献

1
Commentary on the Issue of Infection: Focus on Some Pathogenetic, Clinical, and Epidemiological Aspects.感染问题述评:聚焦一些发病机制、临床及流行病学方面
Vet Sci. 2025 Jun 1;12(6):536. doi: 10.3390/vetsci12060536.
2
Interventions for Old World cutaneous leishmaniasis.旧世界皮肤利什曼病的干预措施。
Cochrane Database Syst Rev. 2017 Dec 1;12(12):CD005067. doi: 10.1002/14651858.CD005067.pub5.
3
Interventions for Old World cutaneous leishmaniasis.旧世界皮肤利什曼病的干预措施。
Cochrane Database Syst Rev. 2017 Nov 17;11(11):CD005067. doi: 10.1002/14651858.CD005067.pub4.
4
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
5
NIH Consensus Statement on Management of Hepatitis C: 2002.美国国立卫生研究院关于丙型肝炎管理的共识声明:2002年。
NIH Consens State Sci Statements. 2002;19(3):1-46.
6
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
7
Community views on mass drug administration for soil-transmitted helminths: a qualitative evidence synthesis.社区对土壤传播蠕虫群体药物给药的看法:定性证据综合分析
Cochrane Database Syst Rev. 2025 Jun 20;6:CD015794. doi: 10.1002/14651858.CD015794.pub2.
8
The clinical effectiveness and cost-effectiveness of enzyme replacement therapy for Gaucher's disease: a systematic review.戈谢病酶替代疗法的临床疗效和成本效益:一项系统评价。
Health Technol Assess. 2006 Jul;10(24):iii-iv, ix-136. doi: 10.3310/hta10240.
9
Active body surface warming systems for preventing complications caused by inadvertent perioperative hypothermia in adults.用于预防成人围手术期意外低温引起并发症的主动体表升温系统。
Cochrane Database Syst Rev. 2016 Apr 21;4(4):CD009016. doi: 10.1002/14651858.CD009016.pub2.
10
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.

引用本文的文献

1
The Role of BRCT Domain from LmjPES in Pathogenesis.来自利什曼原虫多聚(ADP-核糖)聚合酶的BRCT结构域在发病机制中的作用 。 (注:这里原文中的LmjPES可能有误,推测可能是利什曼原虫多聚(ADP-核糖)聚合酶Leishmania major poly(ADP-ribose) polymerase ,按照正确推测翻译了,你可根据实际情况调整 )
Biomolecules. 2025 Aug 19;15(8):1191. doi: 10.3390/biom15081191.

本文引用的文献

1
Cutaneous Leishmaniasis in the Context of Global Travel, Migration, Refugee Populations, and Humanitarian Crises.全球旅行、移民、难民群体及人道主义危机背景下的皮肤利什曼病
Clin Pract. 2025 Apr 8;15(4):77. doi: 10.3390/clinpract15040077.
2
Wildlife as a Sentinel for Pathogen Introduction in Nonendemic Areas: First Detection of in Wildlife in Spain.野生动物作为非流行地区病原体引入的哨兵:西班牙野生动物中首次检测到…… (原文此处不完整,缺少具体检测内容)
Transbound Emerg Dis. 2024 Aug 29;2024:8259712. doi: 10.1155/2024/8259712. eCollection 2024.
3
Plant-derived products as anti-leishmanials which target mitochondria: a review.以线粒体为靶点的植物源抗利什曼原虫产品综述
Expert Rev Mol Med. 2025 Mar 26;27:e15. doi: 10.1017/erm.2025.8.
4
Targeting cysteine protease B to discover antileishmanial drugs: Directions and advances.以半胱氨酸蛋白酶B为靶点发现抗利什曼原虫药物:方向与进展
Eur J Med Chem. 2025 May 5;289:117500. doi: 10.1016/j.ejmech.2025.117500. Epub 2025 Mar 11.
5
Leishmaniases: Strategies in treatment development.利什曼病:治疗研发策略
Parasite. 2025;32:18. doi: 10.1051/parasite/2025009. Epub 2025 Mar 5.
6
An update on recombinant vaccines against leishmaniasis.抗利什曼病重组疫苗的最新进展。
Indian J Med Res. 2024;160(3&4):323-337. doi: 10.25259/IJMR_1040_2024.
7
Uncovering the Significance of JNK/AKT Axis in the Autophagic Regulation of Leishmania major Infection.揭示JNK/AKT轴在硕大利什曼原虫感染自噬调节中的意义。
Mol Microbiol. 2025 Jan;123(1):1-15. doi: 10.1111/mmi.15333. Epub 2024 Dec 3.
8
Atypical cutaneous leishmaniasis: a new challenge to VL elimination in South-East Asia.非典型皮肤利什曼病:东南亚消除内脏利什曼病的新挑战。
Front Cell Infect Microbiol. 2024 Nov 4;14:1454002. doi: 10.3389/fcimb.2024.1454002. eCollection 2024.
9
Immunology of Stress: A Review Article.应激的免疫学:一篇综述文章。
J Clin Med. 2024 Oct 25;13(21):6394. doi: 10.3390/jcm13216394.
10
Immune response to viscerotropic : a comprehensive review.内脏亲嗜性的免疫应答:全面综述。
Front Immunol. 2024 Sep 18;15:1402539. doi: 10.3389/fimmu.2024.1402539. eCollection 2024.